|
The
bill would allow terminally ill individuals to obtain a doctor's
prescription for medication to hasten their death so long as two
physicians agree the patient has no more than six months to live
and is mentally competent.
The measure also would require a patient seeking life-ending
medical aid to undergo a mental health evaluation, to present
two separate requests to an attending physician and for two
witnesses to attest to the patient’s wish to die.
While a doctor could dispense the medication, patients would be
required to take it on their own.
The bill is due to be automatically enacted on April 17 unless
Governor David Ige signs it into law before then or vetoes it.
The advocacy group Compassion and Choices, which backed and
lobbied for the measure, said Ige, a Democrat, is expected to
sign the bill.
The measure was approved by the Hawaii House of Representatives
on a 39-12 vote on March 6, and cleared the Senate on a vote of
23-2. Democrats hold a majority in both bodies.
Six other states - California, Colorado, Montana, Oregon,
Vermont and Washington - already have laws on the books to
legalize medical aid in dying for terminally ill patients,
terminology preferred by advocates to the phrase
"physician-assisted suicide."
The District of Columbia also has enacted such a statute.
Supporters have sought to widen legalization of the practice as
a way to help end-stage cancer and other patients with incurable
diseases to die with less pain and suffering.
Opponents have included some religious groups and some advocates
for the elderly and disabled who have argued that unscrupulous
caregivers or relatives could pressure vulnerable patients to
take their own lives.
Oregon was the first to legalize physician-assisted suicide with
a statute that took effect in 1998. Since then, some 200
end-of-life prescriptions have been written a year and about
two-thirds of them being used, according to Aubrey Hawk, a
spokeswoman for Compassion and Choices.
(Reporting by Steve Gorman in Los Angeles; Editing by Dan
Whitcomb and Michael Perry)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|
